Latest News

Over the past year, we have been highlighting an often-overlooked issue: the emotional toll of having an allergy.   For students living with allergies, the school day can present many dangers which leads to persistent anxiety, including eating in the cafeteria

We’re excited to announce that AllergyWise® for Schools just got even better! Our newly updated resource pack now includes a comprehensive suite of allergy-aware cooking materials — a must-have for every secondary school DT department.  Understanding allergies isn’t just important

From 1 September 2025, new requirements will come into force for wraparound care providers under the Early Years Statutory Framework (EYFS). While expectations for private, voluntary, and independent (PVI) providers – or where Reception children attend – are clearer, school-led

A newly published study from the French Allergy-Vigilance Network (AVN), spanning over two decades from 2002 to 2023, has shed light on an important issue affecting many people who live with food allergies: serious reactions triggered by foods outside the

Antibiotics are life-saving medicines — but only if we use them wisely. Millions of people carry an ‘antibiotic allergy’ label in their medical records. However, research shows that over 90% of these patients are not truly allergic when properly tested.  

Researchers at the University of Southampton are inviting healthcare practitioners to take part in a research study to help prevent food allergy. This research is part of a doctorate project led by Karen Wright and funded by the Biomedical Research

The National Institute for Health and Care Excellence (NICE) has released its final draft guidance recommending Itulazax® (Betula verrucosa)—the first sublingual (under the tongue) tablet immunotherapy, which could help up to 27,000 people in England with moderate to severe birch

Going on holiday is all about relaxing but for people with serious allergies, dining out in unfamiliar locations can bring added stress.

The UK medicines regulator (MHRA) has approved EURneffy®, the country’s first needle-free adrenaline nasal spray for the emergency treatment of serious allergic reactions (anaphylaxis) in adults and children weighing 30kg or more. This new option is expected to become available